Applications of Digital and Computational Pathology and Artificial Intelligence in Genitourinary Pathology Diagnostics – Dr. Mahul B. Amin
Multiparametric MRI in Prostate Cancer Diagnosis and Management: Role of Pathologist – Dr. Cristina Magi-Galluzzi (9:15 AM-10:00 AM, 45 minutes)
Contemporary Update on Prostate Cancer Grading – Dr. Ming Zhou (10:00 AM-10:45 AM, 45 Minutes)
Prostate Cancer in the setting of low- and middle-income countries – challenges and opportunities - Dr. Mahesh Desai (11:00AM - 11:30 AM, 30 minutes)
Prostate Cancer Screening: Controversies and Consensus- The latest guidelines and evidence - Dr. Ravimohan Mavuduru (11:30 AM - 11.45 AM, 15 minutes)
Debate: PSMA PET - CT in the routine staging of prostate cancer (11:45 AM - 12:00 PM, 15 minutes)
For: Dr. Girish K. Parida
Against: Dr. Biswajit Sahoo
Expert comment: Dr. Makarand Kochikar
Oligometastatic prostate cancer: Current understanding and consensus on multi - modality management - Dr. Sandy Srinivas
Moderator : Dr. Surendra N. Senapati
Panelist :
Metastatic hormone sensitive prostate cancer : Choosing wisely - Dr.Krishna Kumar Rathnam (1:10 PM - 1:30 PM, 20 minutes)
Moderator : Dr.Sourav Mishra
Panelist (Final panelist will be notified soon)
Divergent Differentiations and Variant Histologies of Bladder Cancer – Dr. Gladell P. Paner (2:30 PM - 3:05 PM, 35 minutes)
Pathologic sub-staging of bladder cancer – updates, controversies, and guidelines – Dr. Ankur Sangoi (3:05 PM – 3:40 PM, 35 minutes)
Germ Cell Tumors of the Testis: Diagnoses that You Do Not Want to Miss – Dr. Andres M. Acosta (3:40 PM - 4:15 PM, 35 minutes)
Penile Cancer: A pathologist's perspective on current trends in diagnosis, staging, and treatment – Dr. Jasreman Dhillon (4:15 PM -4:50 PM, 35 minutes)
1) Treatment-related neuroendocrine carcinoma of the prostate (Dr. Rajal B. Shah) – 4:50 PM - 5:05 PM, 15 minutes
2) Benign mimics of urothelial carcinoma (Dr. Ankur Sangoi) – 5:05PM - 5:20 PM, 15 minutes
3) Molecularly defined renal cell carcinomas (Dr. Rohit Mehra) – 5:20PM - 5:35 PM, 15 minutes
4) Ductal adenocarcinoma of the prostate (Dr. Ming Zhou) – 5:35PM - 5:50 PM, 15 minutes
7:00 PM Onwards- Cultural program and Dinner
Keynote : Role of HPV in the management of penile cancer: Where do we stand? - Dr. Philippe E. Speiss
Large Gland Lesions of the Prostate: Current Concepts, Controversies, and Future directions – Dr. Rajal Shah (9:15 AM- 10:00 AM, 45 minutes)
How New Developments Impact Diagnosis in Existing Renal Neoplasms – Dr. Sean R. Willamson (10:00 AM- 10:45 AM, 45 minutes)
Pink Cell Tumors of the Kidney: Making Sense – Dr. Rohit Mehra (11:00 AM-11:45 AM, 45 minutes)
Best practice recommendation for immunohistochemical markers in renal cell tumors – Dr. Mahmut Akgul (11:45 AM- 12:30 PM, 45 minutes)
Case based discussion : Clear cell and papillary tumors of the kidney - Dr. Sean R. Willamson (12:30 PM - 12:45 PM, 45 minutes)
Endophytic tumors of the urinary tract - Dr. Gladell P. Paner – (12:45 PM - 1.00 PM, 15 minutes)
Sex cord-stromal tumors of the testis - Dr. Andres M. Acosta – (1:00 PM - 1:15 PM, 15 minutes)
Non-epithelial tumors of the penis Dr. Jasreman Dhillon – (2:00 PM - 2:15 PM, 15 minutes)
Mesenchymal lesions of the GU tract Dr. Mahmut Akgul – (2:15 PM - 2:30 PM, 15 minutes)
Non-muscle invasive bladder cancer: Management principles and recent advances - Dr. Makarand Kochikar (2:30 PM - 2:45 PM, 15 minutes)
Debate : Bladder Preservation Strategies in Bladder Cancer - Combined modality treatment is preferred
over Radical cystectomy in locally advanced bladder cancer (2:45 PM - 3:05 PM, 20 minutes)
Against: Dr. Manas Pradhan : 8 minutes
For: Dr. Suman Das : 8 minutes
Expert comment - Dr. Amit Ghose and Dr. Siddhartha Nanda
Neoadjuvant and adjuvant strategies in bladder cancer.
Moderator : Dr. Vineet Talwar
Panelist (Final panelist will be notified soon)
Metastatic Urothelial Carcinoma: New Horizons with emphasis on Antibody Drug Conjugates: Keynote speech: Dr. Ajjai S. Alva – (3:40 PM - 4:10 PM, 30 minutes)
Clinical management of variant histologies of bladder cancer - Dr. Bivas Biswas, (4:10 PM - 4:25 PM, 15 minutes)
1. Small renal masses: approach and Current guidelines - Dr. Ravindra Sabnis (4:25 PM - 4:40 PM, 15 minutes)
2. Sarcomatoid kidney: important diagnostic and therapeutic considerations – Keynote - Dr. Philippe E. Spiess (4:40 PM - 5:10 PM, 30 minutes)
Inauguration | Cultural program | Banquet Dinner 7 PM Onwards
1. Debate RCC: Adjuvant immunotherapy is the current standard of care in newly diagnosed RCC –
(8:30 AM - 8:50 AM, 20 minutes)
For : Dr. Manikandan Dhanushkodi
Against : Dr. Bhavesh Poladia
Expert comments : Dr. Rejiv Ranjendranath
2. Combining systemic therapy with local therapy (SBRT) in MRCC : Dr. Tanveer Shahid (8:50 AM - 9:05 AM, 15 minutes)
Moderator : Dr. Atul Sharma
Panelist (Final panelist will be notified soon)
Communicating Pathology Results for Personalized Medicine: How Are the Surgical Members of the Society of Urologic Oncology Using Pathology Reports to Guide the Treatment of Prostate Cancer Patients? - Dr. Murali Varma
Genitourinary malignancies: Making sense of Indian data with emphasis on conducting collaborative research - Dr. Atul Batra - (10:30 AM - 10:45 AM, 15 minutes)
Moderator : Dr. Shyam Agarwal
Panelist (Final panelist will be notified soon)
Concluding remarks | Valedictory | Lunch
